Fort Point Capital Partners LLC Avidity Biosciences, Inc. Transaction History
Fort Point Capital Partners LLC
- $874 Million
- Q4 2024
A detailed history of Fort Point Capital Partners LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 31,278 shares of RNA stock, worth $1.01 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
31,278Holding current value
$1.01 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding RNA
# of Institutions
256Shares Held
108MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$357 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$305 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$279 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.11MShares$262 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$256 Million3.76% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.68B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...